Accomplished Pharma CEO and Cannabis Sector
Director Further Strengthens Corporate Governance
TSXV: ACB
VANCOUVER, Oct. 12, 2016 /CNW/ - Aurora Cannabis Inc.
(TSXV: ACB) (FRANKFURT: 21P) (WKN:
A1C4WM) (OTCQB: ACBFF) (the "Company" or "Aurora" or the "Issuer")
is pleased to announce the appointment of Barry Fishman to the Board of
Directors.
Mr. Fishman, who will sit as an independent director, has a
robust record of accomplishment as CEO of three major
pharmaceutical companies, is a Certified Public Accountant (CPA),
and has more than 30 years of experience in executive management,
marketing and finance.
Mr. Fishman is the CEO of international specialty pharmaceutical
company Merus Labs (TSX: MSL) (NASDAQ: MSLI), where he has led the
company to more than tripling sales and EBITDA over the last two
fiscal years. Previously, he has served as CEO of both Teva Canada and Taro
Canada, and is a past Chair of the Canadian Generic
Manufacturers Association. He began his pharmaceutical career at
Eli Lilly, where he advanced through several cross-functional
leadership roles, including Vice President of Marketing. Mr.
Fishman also has critical insights into the development of the
cannabis sector, having previously served on the Board of Directors
of Canopy Growth Corporation and Bedrocan Cannabis Corp.
"Barry is an outstanding addition to the Board, bringing
extensive marketing, finance and capital markets experience, and
further enhancing our corporate governance," said Terry Booth, CEO. "His network and reputation,
along with his wise judgment, will serve the Company and our
shareholders well as we continue on our rapid growth trajectory,
which includes expanding our production capacity, transitioning to
profitable operations, and further establishing our leadership
position in the Canadian cannabis industry."
"I am delighted to join Aurora, and to become part of this
dynamic team that will continue to provide leadership and drive
innovation in the cannabis sector," said Mr. Fishman. "This Company
has been a standout in terms of its rapid growth, management and
Board strength, disciplined execution of its strategic plan, and
vision for the future of the industry. I look forward to playing a
key role in Aurora's governance and strategic decision-making."
In connection with Mr. Fishman's appointment as a Director, the
Company granted him stock options to acquire 350,000 common shares
in the capital of the Company, exercisable at $2.38 per share, expiring in five years. These
options will vest evenly on a quarterly basis over a period of one
year.
About Aurora
Aurora's wholly-owned subsidiary, Aurora Cannabis Enterprises
Inc., is a licensed producer of medical cannabis pursuant to Health
Canada's Access to Cannabis for Medical Purposes Regulations
(ACMPR) and operates a 55,200 square foot, expandable,
state-of-the-art production facility in Mountain View County,
Alberta, Canada. Aurora trades on
the TSX Venture Exchange under the symbol "ACB".
On behalf of the Board of Directors, AURORA CANNABIS INC.
Terry Booth, CEO
This news release contains statements about the Company's
expectations regarding production capacity, production yields and
other aspects of its anticipated future operations that are
forward-looking in nature and, as a result, are subject to certain
risks and uncertainties. Although the Company believes that the
expectations reflected in these forward-looking statements are
reasonable, undue reliance should not be placed on them as actual
results may differ materially from the forward-looking statements.
Such forward-looking statements are estimates reflecting the
Company's best judgment based upon current information and involve
a number of risks and uncertainties, and there can be no assurance
that other factors will not affect the accuracy of such
forward-looking statements. Such factors include but are not
limited to the Company's ability to obtain the necessary financing
and the general impact of financial market conditions, the yield
from marijuana growing operations, product demand, changes in
prices of required commodities, competition, government regulations
and other risks set out in the Company's management's discussion
and analysis filed on SEDAR. The forward-looking statements
contained in this news release are made as of the date hereof, and
the Company undertakes no obligation to update publicly or revise
any forward-looking statements or information, except as required
by law.
Neither the TSX Venture Exchange nor its Regulation
Services Provider (as that term is defined in the policies of the
TSX Venture Exchange) accepts responsibility for the adequacy or
accuracy of this release.
SOURCE Aurora Cannabis Inc.